156 related articles for article (PubMed ID: 8877991)
1. Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study.
Zironi G; Rossi C; Siringo S; Galaverni C; Gaiani S; Piscaglia F; Bolondi L
Liver; 1996 Aug; 16(4):225-34. PubMed ID: 8877991
[TBL] [Abstract][Full Text] [Related]
2. [Splanchnic hemodynamic effects of somatostatin and octreotide in cirrhotic patients. A Doppler ultrasonographic study].
Fernández Pérez FJ; Jiménez Sáenz M; García Montes JM; Rebollo Bernárdez J; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2008 Sep; 100(9):552-9. PubMed ID: 19025306
[TBL] [Abstract][Full Text] [Related]
3. Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study.
McCormick PA; Biagini MR; Dick R; Greenslade L; Chin J; Cardin F; Wagstaff D; McIntyre N; Burroughs AK
Hepatology; 1992 Nov; 16(5):1180-6. PubMed ID: 1427656
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis.
Sabbà C; Buonamico P; Vendemiale G; Berardi E; Antonica G; Palmieri V; Merkel C; Palasciano G
Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):163-9. PubMed ID: 11246616
[TBL] [Abstract][Full Text] [Related]
5. [Effects of two different dosages of octreotide on portal pressure and hepatic hemodynamics in cirrhotic portal hypertensive patients after portal-azygous devascularization and splenectomy].
Lu SC; Meng FK; Ding HG; Zhang JG; Ding L; Wang SZ
Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):290-3. PubMed ID: 17637266
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol.
Iwao T; Oho K; Sakai T; Sato M; Nakano R; Yamayaki M; Toyonaga A; Tanikawa K
J Hepatol; 1998 May; 28(5):847-55. PubMed ID: 9625321
[TBL] [Abstract][Full Text] [Related]
7. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
Ludwig D; Schädel S; Brüning A; Schiefer B; Stange EF
Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
[TBL] [Abstract][Full Text] [Related]
8. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Albillos A; Rossi I; Iborra J; Lledó JL; Calleja JL; Barrios C; García P; Escartín P
J Hepatol; 1994 Jul; 21(1):88-94. PubMed ID: 7963427
[TBL] [Abstract][Full Text] [Related]
9. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
[TBL] [Abstract][Full Text] [Related]
10. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease.
Matrella E; Valatas V; Notas G; Roumpaki H; Xidakis C; Hadzidakis A; Mouzas I; Kouroumalis E
Aliment Pharmacol Ther; 2001 Jun; 15(6):857-64. PubMed ID: 11380324
[TBL] [Abstract][Full Text] [Related]
11. Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: effect of octreotide.
McCormick PA; Seifalian AM; Stansby G; McGann G; Collins P; Chin J; McIntyre N; Dick R; Burroughs AK
J Hepatol; 1993 Jan; 17(1):20-7. PubMed ID: 8383155
[TBL] [Abstract][Full Text] [Related]
12. Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study.
Ludwig D; Terai S; Brüning A; Stange EF
Aliment Pharmacol Ther; 1999 Aug; 13(8):1119-29. PubMed ID: 10468691
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
15. Effects of octreotide on postprandial systemic and hepatic hemodynamics in patients with postnecrotic cirrhosis.
Lin HC; Tsai YT; Huang CC; Meng HC; Lee FY; Wang SS; Lee SD; Lo KJ
J Hepatol; 1994 Sep; 21(3):424-9. PubMed ID: 7836713
[TBL] [Abstract][Full Text] [Related]
16. [The effects of octreotide on portal hemodynamics in patients with liver cirrhosis].
Zhu Q; Jiang XH; Yi F; Jiang Y; Sun YW; Yuan YZ; Wu YL
Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):16-8. PubMed ID: 14990014
[TBL] [Abstract][Full Text] [Related]
17. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Brinch K; Henriksen JH; Becker U
J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
[TBL] [Abstract][Full Text] [Related]
18. Specificity of splenic blood flow in liver cirrhosis.
Perisić MD; Culafić DjM; Kerkez M
Rom J Intern Med; 2005; 43(1-2):141-51. PubMed ID: 16739874
[TBL] [Abstract][Full Text] [Related]
19. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS.
Schiedermaier P; Göke B; Sauerbruch T
Am J Gastroenterol; 2001 Jul; 96(7):2218-24. PubMed ID: 11467656
[TBL] [Abstract][Full Text] [Related]
20. Effect of octreotide on hemodynamics and glucagon levels in portal hypertensive rabbits.
Lin PW; Shan YS
J Formos Med Assoc; 1994 Aug; 93(8):668-72. PubMed ID: 7858449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
